Navigation Links
GreenField Ethanol and Enerkem Announce Plans to Make Cellulosic Ethanol a Commercial Reality
Date:3/11/2008

TORONTO and MONTREAL, March 11 /PRNewswire/ - GreenField Ethanol, Canada's largest ethanol producer, and Enerkem, a leading gasification and catalysis technology company, have signed a Binding Term Sheet outlining their plan to produce cellulosic ethanol on a commercial scale.

"We are excited to work with Enerkem to make cellulosic ethanol a commercial reality in Canada," said Bob Gallant, President and CEO of GreenField Ethanol. "Canadian consumers are looking for a greener, affordable alternative to fossil fuels and GreenField is delivering by expanding its corn ethanol business to include new bio-based fuels," added Frank Dottori, Managing Director of the company's Cellulosic Ethanol division.

The companies agreed to terms that will see them collaborate 50/50 on joint projects to design, build and operate commercial cellulosic ethanol plants using Enerkem technology in specified geographic areas. The first plant location has been secured within Canada and will be announced in the coming weeks. A second plant is also in development.

Enerkem's technology converts biomass such as sorted municipal solid waste and urban wood residues into cellulosic ethanol and other biofuels. It eliminates more than two tonnes of greenhouse gases (GHGs) per tonne of residues used as feedstock. The company's founders have been active in gasification for many years. Enerkem's pilot plant, which has run more than 3,000 hours since 2003, produces syngas, methanol and cellulosic ethanol. The company is currently building a commercial scale cellulosic ethanol demonstration plant in Westbury, Quebec.

"This partnership is an important milestone in achieving Enerkem's goal to commercialize cellulosic ethanol", said Mr. Vincent Chornet, Chief Executive Officer of Enerkem. "By joining forces with GreenField Ethanol, we are poised to become the Canadian leaders in the production and distribution of new generation biofuels. GreenField's experience in building an
'/>"/>

SOURCE Enerkem Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
2. Genencor Launches First Ever Commercial Enzyme Product for Cellulosic Ethanol
3. Masada Teams With Leading Waste Management Firm to Produce Ethanol From Municipal Solid Waste in the Dominican Republic
4. Healthcare Technologies Ltd. (NASDAQ: HCTL) Announces Extension of Letters of Intent to Acquire Majority Interest in Two Ethanol Plants
5. Enerkem announces progress on construction of Canadas first cellulosic ethanol plant
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):MSU research may lead to new ways to control honeybee parasite 277 percent of European pigs are castrated without anesthetic 2Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and 24200 Million Principal Amount of Convertib 13439 1Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and 24200 Million Principal Amount of Convertib 13439 2Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and 24200 Million Principal Amount of Convertib 13439 3Watson Pharmaceuticals and Arrow Group Receive FTC Second Request 53919 1Watson Pharmaceuticals and Arrow Group Receive FTC Second Request 53919 2Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 1Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 2Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 3Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 4Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 5Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 6Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 7Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 8Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 9Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 10Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 11Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 12Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 13Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 14Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 15Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 16Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 17Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 18Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 19Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 20Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 21Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 22